InvestorsHub Logo
Followers 17
Posts 752
Boards Moderated 0
Alias Born 10/20/2013

Re: loanranger post# 140973

Saturday, 02/27/2016 5:19:14 PM

Saturday, February 27, 2016 5:19:14 PM

Post# of 403076
This is a timeline of Discover1 Phase3 of Dalbavancin.
If CTIX can get patients enrolled faster than the 18 months
it too Durata, it seems the the trial itself is very swift.



Study first received: April 18, 2011

https://clinicaltrials.gov/ct2/show/NCT01339091

100 % enrollment: September 6, 2012

Preliminary top-line data: December 11, 2012

Additional top-line data: January 4, 2013

http://www.duratatherapeutics.com/news-media/press-releases/detail/7944/durata-therapeutics-meets-primary-endpoints-for-ema-review

SEE ALSO:

http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=4017
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News